PIK3CA testing and treatment patterns among patients with metastatic breast cancer in US community clinical practice

被引：0
|
作者：
Kim, Eunice
Dhillon, Preet Kaur
Lambert, Peter
Cheng, Anna
Basho, Reva K.
机构：
[1] Genentech Inc, San Francisco, CA USA
[2] Ellison Inst Technol, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13059
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients
    Meier-Stiegen, F.
    Schneck, H.
    Blassl, C.
    Neves, R. Pedro
    Janni, W.
    Fehm, T.
    Neubauer, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 5
  • [22] The High Frequency of PIK3CA Mutations in Iranian Breast Cancer Patients
    Tabesh, Ghasem Azizi
    Izadi, Pantea
    Fereidooni, Forouzandeh
    Razavi, Amir Nader Emami
    Bazzaz, Javad Tavakkoly
    CANCER INVESTIGATION, 2017, 35 (01) : 36 - 42
  • [23] Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
    Higgins, Michaela J.
    Jelovac, Danijela
    Barnathan, Evan
    Blair, Brian
    Slater, Shannon
    Powers, Penny
    Zorzi, Jane
    Jeter, Stacie C.
    Oliver, George R.
    Fetting, John
    Emens, Leisha
    Riley, Carol
    Stearns, Vered
    Diehl, Frank
    Angenendt, Philipp
    Huang, Peng
    Cope, Leslie
    Argani, Pedram
    Murphy, Kathleen M.
    Bachman, Kurtis E.
    Greshock, Joel
    Wolff, Antonio C.
    Park, Ben H.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3462 - 3469
  • [24] Implications of somatic TP53 and PIK3CA mutations in patients with metastatic breast cancer who underwent germline BRCA testing
    Yam, Clinton
    Barrera, Angelica Gutierrez
    Huang, Davis
    Lin, Xinyi
    Litton, Jennifer K.
    Arun, Banu
    CANCER RESEARCH, 2018, 78 (04)
  • [25] Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer
    Cardinali, Barbara
    De Luca, Giuseppa
    Tasso, Roberta
    Coco, Simona
    Garuti, Anna
    Buzzatti, Giulia
    Sciutto, Andrea
    Arecco, Luca
    Villa, Federico
    Carli, Franca
    Reverberi, Daniele
    Quarto, Rodolfo
    Dono, Mariella
    Del Mastro, Lucia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [26] Frequency of PIK3CA Mutations in Chinese HER2+Metastatic Breast Cancer Patients and Association with Clinical Benefit to Lapatinib and Capecitabine Treatment.
    Xu, B.
    Zefei, J.
    Chua, D.
    Shao, Z.
    Luo, R.
    Wang, X.
    Yuan, P.
    Newstat, B.
    Liu, Y.
    Gagnon, R.
    Chi, H.
    Martin, A-M
    Stein, S.
    Wang, L.
    CANCER RESEARCH, 2009, 69 (24) : 583S - 583S
  • [27] Role of ddPCR in the diagnosis of PIK3CA in breast cancer
    Grudeva-Popova, Z.
    Raicheva, G.
    Ivanov, H.
    Stojanova, V.
    Linev, A.
    Jeljazkov, I.
    ANNALS OF ONCOLOGY, 2021, 32 : S496 - S496
  • [28] PIK3CA mutations in breast cancer: A Tunisian series
    Ben Rekaya, Mariem
    Sassi, Farah
    Saied, Essya
    Kacem, Linda Bel Haj
    Mansouri, Nada
    Zarrouk, Sinda
    Azouz, Saifeddine
    Rammeh, Soumaya
    PLOS ONE, 2023, 18 (05):
  • [29] Plasma PIK3CA Mutation Testing in Advanced Breast Cancer Patients for Personalized Medicine: A Value Proposition
    Ferreira-Gonzalez, Andrea
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (05): : 1076 - 1089
  • [30] Mutation of the PIK3CA gene in ovarian and breast cancer
    Campbell, IG
    Russell, SE
    Choong, DYH
    Montgomery, KG
    Ciavarella, ML
    Hooi, CSF
    Cristiano, BE
    Pearson, RB
    Phillips, WA
    CANCER RESEARCH, 2004, 64 (21) : 7678 - 7681
12345